Unbiased vs. biased approaches to the identification of cancer signatures - The case of lung cancer

被引:13
作者
Bianchi, Fabrizio [1 ]
Nicassio, Francesco [1 ]
Di Fiore, Pier Paolo [1 ,2 ,3 ]
机构
[1] Fdn Inst FIRC Oncol Mol, IFOM, I-20139 Milan, Italy
[2] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy
[3] Ist Europeo Oncol, Dipartimento Oncol Sperimentale, Milan, Italy
关键词
lung cancer; prognosis; survival; gene expression; microarray; NSCLC; cancer signatures;
D O I
10.4161/cc.7.6.5591
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression profiling analysis of human cancers is a promising approach to obtain precise molecular classification of cancers, to develop stratification tools for therapeutic regimens, and to predict the biological behavior of neoplasia. Direct profiling of human cancers ( herein defined as "the unbiased approach") presents, however, intrinsic problems connected with the high genetic noise embedded in the system. This, in turn, leads to fitting of the noise in the data ( the so-called "overtraining") with consequent instability of the identified signatures, when applied on different cohorts of patients. To circumvent these problems, "biased approaches" - which exploit the molecular knowledge of cancer obtained in model systems - are being developed. Biased approaches, however, are not problem-free, in that they provide information limited to single oncogenic events, thereby failing, at least in principle, to capture the complex repertoire of alterations of human cancers. In this review, we compare the two approaches and provide a test case, from our studies, of how "integrated" strategies, which combine biased and unbiased approaches, might lead to the identification of stable and reliable predictive signatures in cancer.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 92 条
[81]  
Travis W, 2004, PATHOLOGY GENETICS T
[82]   A gene-expression signature as a predictor of survival in breast cancer. [J].
van de Vijver, MJ ;
He, YD ;
van 't Veer, LJ ;
Dai, H ;
Hart, AAM ;
Voskuil, DW ;
Schreiber, GJ ;
Peterse, JL ;
Roberts, C ;
Marton, MJ ;
Parrish, M ;
Atsma, D ;
Witteveen, A ;
Glas, A ;
Delahaye, L ;
van der Velde, T ;
Bartelink, H ;
Rodenhuis, S ;
Rutgers, ET ;
Friend, SH ;
Bernards, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :1999-2009
[83]   Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance [J].
Wei, Guo ;
Twomey, David ;
Lamb, Justin ;
Schlis, Krysta ;
Agarwal, Jyoti ;
Stam, Ronald W. ;
Opferman, Joseph T. ;
Sallan, Stephen E. ;
den Boer, Monique L. ;
Pieters, Rob ;
Golub, Todd R. ;
Armstrong, Scott A. .
CANCER CELL, 2006, 10 (04) :331-342
[84]   ASSOCIATION BETWEEN AN ONCOGENE AND AN ANTI-ONCOGENE - THE ADENOVIRUS E1A PROTEINS BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
WHYTE, P ;
BUCHKOVICH, KJ ;
HOROWITZ, JM ;
FRIEND, SH ;
RAYBUCK, M ;
WEINBERG, RA ;
HARLOW, E .
NATURE, 1988, 334 (6178) :124-129
[85]  
Wigle DA, 2002, CANCER RES, V62, P3005
[86]   Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking [J].
Wingo, PA ;
Ries, LAG ;
Giovino, GA ;
Miller, DS ;
Rosenberg, HM ;
Shopland, DR ;
Thun, MJ ;
Edwards, BK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (08) :675-690
[87]  
Wistuba II, 2000, CANCER RES, V60, P1949
[88]  
Wistuba II, 2000, CLIN CANCER RES, V6, P2604
[89]   Smoking molecular damage in bronchial epithelium [J].
Wistuba, II ;
Mao, L ;
Gazdar, AF .
ONCOGENE, 2002, 21 (48) :7298-7306
[90]   Molecular footprints of human lung cancer progression [J].
Yokota, J ;
Kohno, T .
CANCER SCIENCE, 2004, 95 (03) :197-204